TABLE 2.
Survived | Deceased | P | |
---|---|---|---|
n | 1,885 | 496 | |
Men | 922 (48.9) | 262 (52.8) | 0.12 |
Age (years) | 65.9 ± 10.2 | 74.1 ± 8.5 | <0.0001 |
Duration of diabetes (years) | 10.2 ± 7.8 | 12.6 ± 8.4 | <0.0001 |
CRP (mg/dl) | 2.5 (1.2–5.3) | 3.7 (1.6–9.1) | <0.0001 |
<1.6 | 642 (34.1) | 117 (23.6) | <0.0001 |
1.6–4.4 | 671 (35.6) | 163 (32.8) | |
>4.4 | 572 (30.3) | 216 (43.6) | |
BMI (kg/m2) | 28.9 ± 5.0 | 28.0 ± 5.4 | 0.0009 |
Waist circumference (cm) | 98.2 ± 12.2 | 98.3 ± 12.8 | 0.82 |
Systolic blood pressure (mmHg) | 145.5 ± 16.2 | 146.7 ± 17.1 | 0.14 |
Diastolic blood pressure (mmHg) | 83.0 ± 8.2 | 82.3 ± 8.4 | 0.10 |
Hypertension | 1,653 (87.9) | 458 (92.3) | 0.005 |
Glucose (mg/dl) | 171.5 ± 53.5 | 178.3 ± 60.0 | 0.014 |
A1C (%) | 7.0 ± 1.7 | 7.3 ± 1.9 | 0.0003 |
Total cholesterol (mg/dl) | 213.1 ± 40.0 | 206.3 ± 40.2 | 0.001 |
LDL cholesterol (mg/dl) | 129.0 ± 34.2 | 122.3 ± 33.9 | 0.0002 |
HDL cholesterol (mg/dl) | 54.7 ± 14.8 | 55.0 ± 16.6 | 0.70 |
Triglycerides (mg/dl) | 129.6 (92–177) | 127.7 (87–175) | 0.57 |
ApoA1 (mg/dl) | 154.9 ± 38.8 | 150.7 ± 39.1 | 0.03 |
ApoB (mg/dl) | 102.8 ± 26.3 | 100.0 ± 28.3 | 0.04 |
ApoB/apoA1 | 0.72 ± 0.33 | 0.72 ± 0.34 | 0.99 |
Creatinine (mg/dl) | 0.83 (0.69–0.97) | 0.93 (0.73–1.11) | <0.001 |
Fibrinogen (g/l) | 372.1 ± 68.5 | 406.9 ± 110.4 | <0.0001 |
Uric acid (mg/dl) | 5.52 ± 1.73 | 6.04 ± 2.51 | <0.0001 |
AER (μg/min) | 12.1 (4.2–25.5) | 21.3 (6.4–49.3) | <0.0001 |
20–200 | 377 (24.3) | 113 (35.3) | |
>200 | 73 (4.7) | 28 (8.8) | |
CVD | 353 (18.7) | 157 (31.6) | 0.0001 |
Smoking | |||
Former smoker | 534 (29.3) | 166 (34.9) | 0.03 |
Smoker | 291 (16.0) | 60 (12.6) | |
Glucose-lowering treatment | |||
Diet | 303 (71.0) | 62 (12.7) | <0.0001 |
Oral drugs | 1,402 (75.4) | 337 (68.9) | |
Insulin | 155 (8.3) | 90 (18.4) | |
Statins | 379 (20.1) | 98 (19.8) | 0.98 |
Data are means ± SD, n (%), or geometric means (95% CI).